Your Location:
Home >
Browse articles >
TNC-targeted CAR-macrophage therapy alleviates liver fibrosis in mice
TNC-targeted CAR-macrophage therapy alleviates liver fibrosis in mice
- “A research team introduces its progress in liver fibrosis treatment. They engineered TNC-targeted CAR-macrophages, verified their ability to engulf activated hepatic stellate cells and reduce fibrosis via TLR4/NF-κB and integrin/FAK pathways, which provides solutions for liver disease therapy.”
- Military Medical Research Vol. 13, Issue 5, Pages: 706-727(2026)
DOI: 10.1186/s40779-025-00667-3
Accepted:31 October 2025
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 8 ) Tabs( 0 )
References
Publication Info
Metrics
61
Views
56
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
ZBP1 activated by mitochondrial damage binds to STAT3 to suppress Legumain production and exacerbate macrophage inflammation in Klebsiella pneumoniae-induced sepsis
Dietary methionine supplementation promotes mice hematopoiesis after irradiation
Adipose tissue macrophages: implications for obesity- associated cancer
Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies
Engineered exosomes for diabetic foot ulcers: lessons learned, challenges remain
Related Author
Xiu-Wen Wu
Li-Ting Deng
Huan Yang
Xu-Fei Zhang
Ni Kuang
Jian-An Ren
Yun Zhao
Ye-Ting Zhu
Related Institution
Nanjing Medical Key Laboratory of Laryngopharynx-Head and Neck Oncology, the Affiliated BenQ Hospital of Nanjing Medical University
Nanjing Medical University
Department of Emergency Surgery, the Affiliated Hospital of Qingdao University
Department of Infectious Diseases, Chongqing Key Laboratory for Research of Infectious Diseases, Southwest Hospital, Army Medical University
Department of General Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University

